In PLoS Medicine, Nathan Ford and colleagues from the humanitarian agency Médecins Sans Frontières (MSF; Doctors Without Borders) describe their experience of providing HIV prevention and treatment in two prisons in Thailand.
HIV is more common among prisoners than among the general population of Thailand—one study, for example, in Klong Prem Central Prison, Bangkok, found that [...]

A survey of nearly 700 surgical residents in 17 U.S. medical centers finds that more than half failed to report needle-stick injuries involving patients whose blood could be a source of HIV, hepatitis and other infections.
Authors of the report — appearing in the June 28 issue of The New England Journal of Medicine — say [...]

Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
CMV, a type of herpes virus, is the leading viral cause of birth defects and a serious problem in patients with compromised [...]

Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has been engaged by GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based biotechnology company, to manufacturer its HIV-1 DNA (AIDS) vaccine. This vaccine will be utilized in GeoVax’s advanced Phase 2 human trials planned to [...]

Abbott’s Chairman and Chief Executive Officer Miles D. White joined Tanzania’s Minister of Health and Social Welfare the Hon. David Mwakyusa in Arusha today to dedicate the new Abbott Fund-supported laboratory at Mt. Meru Hospital. Mr. White also announced two new initiatives that will improve overall access to health care, and expand access to HIV [...]

By a vote of 206-226 the House of Representatives defeated an amendment offered by Representative Joseph Pitts (R-PA) to reinstate the “33 percent” abstinence-until-marriage earmark in the President’s Emergency Plan for AIDS Relief (PEPFAR).
The Foreign Operations Appropriations bill contains a provision that waives the mandatory abstinence-until-marriage earmark for FY 2008. The provision provides the administration [...]

The Senate Appropriations Committee yesterday recommended a very modest overall increase for domestic HIV/AIDS care and treatment programs and flat funding for treatment education and training and domestic HIV prevention programs. The Senate committee’s proposed funding is much less than recommendations from the House of Representatives subcommittee and significantly less then the actual needs for [...]

There are 250,000-350,000 people in the United States living with HIV who do not yet know that they are infected. At least 40,000 people are infected with HIV in the U.S. each year. People who receive an early diagnosis of HIV have substantially better health outcomes than people who are diagnosed at late stages of [...]

Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today announced that by the end of June, two new clinical sites - in Newark, New Jersey and Philadelphia, Pennsylvania - will be ready to enroll patients in a Phase 2 study to test low-dose interferon alpha lozenges administered orally to HIV-positive subjects with oral warts. The Company’s goal [...]

Human resistance to a retrovirus that infected chimpanzees and other nonhuman primates 4 million years ago ironically may be at least partially responsible for the susceptibility of humans to HIV infection today.
These findings, reported by a team of researchers at Fred Hutchinson Cancer Research Center in the June 22 issue of Science, provide a better [...]